3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
23
Melanoma
21
Carcinoma, Renal Cell
21
Neoplasms
8
Lung Neoplasms
8
Colorectal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Prostatic Neoplasms
7
Neoplasm Metastasis
6
Carcinoma, Transitional Cell
6
Carcinoma, Hepatocellular
6
Stomach Neoplasms
5
Rectal Neoplasms
5
Hodgkin Disease
5
Adenocarcinoma Of Esophagus
5
Triple Negative Breast Neoplasms
4
Ovarian Neoplasms
4
Nasopharyngeal Carcinoma
4
Endometrial Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Thyroid Neoplasms
3
Pancreatic Neoplasms
3
Oropharyngeal Neoplasms
3
Multiple Myeloma
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Colonic Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Interventions
Etoposide
3
daratumumab
2
Vincristine
2
Prednisone
2
Doxorubicin
2
Cyclophosphamide
2
prednylidene
1
pomalidomide
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
Rituximab
1
Peripheral Blood Stem Cell Transplantation
1
Melphalan
1
Dexamethasone
1
Cytarabine
1
Carmustine
1
Bortezomib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Plasmablastic Lymphoma
×
Nivolumab
×
30 days
×
Clear all
No trials found.